• APC Drug Shortage Compounding Survey 2025-2026

    APC is hearing that the SAFE Drugs Act (H.R. 6509 /S. 3794) may soon receive consideration in the U.S. Senate. If the bill advances, lawmakers need to understand that compounding pharmacies don’t just respond to GLP-1 shortages – they have long helped patients access a wide range of medications during FDA-recognized shortages. This survey will help us quantify that impact and strengthen our advocacy efforts. If your pharmacy has compounded medications because of an FDA drug shortage in 2025-2026, please take a few minutes to complete this survey. The information will be used in APC's federal advocacy efforts and may be reported only in the aggregate unless we receive your permission to do otherwise.
  • 1. Has your pharmacy compounded medications due to an FDA-declared drug shortage in 2025-2026?*
  • 2. Which drugs has your pharmacy compounded in 2025-2026 due to an FDA-recognized shortage? Check all that apply.

  • Cancer medications
  • Pediatric / Oral medications
  • Hormones
  • Hospital / Sterile medications
  • 3. Approximately how many prescriptions or preparations did your pharmacy compound for each medication in 2025-2026?

  • 7. May APC contact you if we have follow-up questions?*
  • Format: (000) 000-0000.
  • Should be Empty: